Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study
Keitaro Shimozaki, Izuma Nakayama, Daisuke Takahari, Kengo Nagashima, Koichiro Yoshino, Koshiro Fukuda, Shota Fukuoka, Hiroki Osumi, Mariko Ogura, Takeru Wakatsuki, Akira Ooki, Eiji Shinozaki, Keisho Chin, Kensei Yamaguchi
Published in Journal of gastric cancer (2023)
Get full text
Published in Journal of gastric cancer (2023)
Journal Article